a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency
Clinical trial NCT05922436 · UNKNOWN
Trial details
- NCT number
- NCT05922436
- Sponsor
- Qilu Pharmaceutical (Hainan) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-15
- Primary completion
- 2024-05-24
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.